ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
12.88
-0.01 (-0.08%)
Sep 16, 2026, 4:00 PM EDT - Market closed
ProMIS Neurosciences Employees
As of December 31, 2025, ProMIS Neurosciences had 11 total employees, including 10 full-time and 1 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$3,838,931
Market Cap
115.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 11 | 3 | 37.50% | 10 | 1 |
| Dec 31, 2024 | 8 | 1 | 14.29% | 7 | 1 |
| Dec 31, 2023 | 7 | 0 | - | 6 | 1 |
| Dec 31, 2022 | 7 | 1 | 16.67% | 6 | 1 |
| Dec 31, 2021 | 6 | 5 | 500.00% | 5 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Nautilus Biotechnology | 127 |
| Cibus | 118 |
| Inovio Pharmaceuticals | 112 |
| Rani Therapeutics Holdings | 71 |
| OnKure Therapeutics | 45 |
| Vivani Medical | 42 |
| Genelux | 26 |
PMN News
- 1 day ago - ProMIS Neurosciences Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 days ago - ProMIS Neurosciences Transcript: Moody Capital Disruptive Growth & Life Science Conference - Transcripts
- 7 days ago - ProMIS Neurosciences Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 16 days ago - ProMIS Neurosciences to Participate in Upcoming Conferences and Events in September - GlobeNewsWire
- 26 days ago - ProMIS Neurosciences price target lowered to $29 from $30 at Roth Capital - TheFly
- 4 weeks ago - ProMIS Neurosciences reports Q2 EPS ($1.28), consensus ($1.90) - TheFly
- 4 weeks ago - ProMIS Neurosciences price target raised to $100 from $69 at Guggenheim - TheFly
- 4 weeks ago - ProMIS Neurosciences Earnings Call Transcript: Q2 2026 - Transcripts